Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property is a research paper published in Expert Opinion on Therapeutic Patents (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R61HL156158
NIH
Grant: NHLBI
National Institutes of Health
Grant: 1S10OD021756-01A1
X-ray Crystallographic Data Collection System
National Institutes of Health
Grant: 5R01MD009124-05
Hemoglobin Modifiers for Sickle Cell Disease Therapy
National Institutes of Health
Grant: 5R61HL156158-02
Targeted Identification of Dual Acting Antisickling Agents for Sickle Cell Disease Therapy
NIMHD NIH HHS
Grant: R01 MD009124
NHLBI NIH HHS
Grant: R33 HL156158
NIH HHS
Grant: S10 OD021756
FWCI
1.62
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals